Furthermore, COVID-19 can induce the release of cytokines, such as interleukin-1β, interleukin-6, and tumor necrosis factor-α, which may lower serotonin levels by altering its biosynthesis, release, and reuptake. The gene discussed is IL6; the disease is COVID-19.